According to Axogen's latest financial reports the company's current revenue (TTM) is $0.15 B. In 2022 the company made a revenue of $0.13 B an increase over the years 2021 revenue that were of $0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.15 B | 14.74% |
2022 | $0.13 B | 8.81% |
2021 | $0.12 B | 13.41% |
2020 | $0.11 B | 5.24% |
2019 | $0.10 B | 27.13% |
2018 | $83.93 M | 38.91% |
2017 | $60.42 M | 47% |
2016 | $41.1 M | 50.41% |
2015 | $27.33 M | 62.52% |
2014 | $16.81 M | 53.62% |
2013 | $10.94 M | 42.33% |
2012 | $7.69 M | 58.61% |
2011 | $4.84 M | 460.22% |
2010 | $0.86 M | -96.53% |
2009 | $24.91 M | 34160.34% |
2008 | $0.07 M | |
2005 | $0.44 M | |
2003 | $7.23 M | 5.62% |
2002 | $6.85 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Medtronic MDT | $32.32 B | 20,225.51% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | $42.85 B | 26,852.05% | ๐บ๐ธ USA |
Boston Scientific BSX | $14.24 B | 8,855.30% | ๐บ๐ธ USA |